← FDA Drug Approvals (Drugs@FDA)
DESMOPRESSIN ACETATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2022-11-16
Drug application
- FDA Application #
ANDA216922- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DESMOPRESSIN ACETATE
- Generic name
- DESMOPRESSIN ACETATE
- Active ingredients
- DESMOPRESSIN ACETATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- GLAND
- Manufacturer
- Fresenius Kabi USA, LLC
- First approval
- 2022-11-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown